Researchers at the University of Michigan Health Rogel Cancer Center are one step closer to understanding how pediatric DIPG tumors work.
Clive Svendsen, PhD, executive director of the Board of Governors Regenerative Medicine Institute and professor of Medicine and Biomedical Sciences at Cedars-Sinai, is developing new treatments and models for amyotrophic lateral sclerosis (ALS) using stem cells.
People who experience prolonged depressive symptoms starting in young adulthood may have worse thinking and memory skills in middle age, according to a study published in the June 12, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.
People who give birth to infants less than 5.5 pounds may be more likely to have memory and thinking problems later in life than people who give birth to infants who do not have a low birth weight, according to a study published in the June 12, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.
The AANS and the CNS are optimistic that Congress will pass this critical legislation this year.
Harvard Medical School researchers are studying one of the most mysterious — and most essential — senses
The ability to imagine is pivotal for human development, driving creativity and problem-solving. It may also influence our relationship with others, according to new research.
The discovery of how intricate networks of blood vessels in the eye and brain are formed could inspire new treatments for glaucoma, diabetic retinopathy, and stroke.
Researchers have developed — and shared — a process for creating brain cortical organoids — essentially miniature artificial brains with functioning neural networks
Cedars-Sinai has launched a program to help people 40 and older who do not have Alzheimer’s disease but want to understand—and reduce—their risk for developing the illness.
By super cooling a molecule on the surface of brain cells down to about minus 180 degrees Celsius — nearly twice as cold as the coldest places in Antarctica — scientists at Johns Hopkins Medicine say they have determined how a widely-used epilepsy drug works to dampen the excitability of brain cells and help to control, although not cure, seizures.
New research from Washington University School of Medicine in St. Louis and other institutions supports earlier findings that indicate that anesthesia is no more hazardous for the brain at higher doses than at lower doses.
Be among the first to hear breaking news in food and nutrition science at NUTRITION 2024, the annual flagship meeting of the American Society for Nutrition held June 29–July 2 at McCormick Place in Chicago.
ILAE produced a podcast episode in 2023 in which Dr. Hector Garcia talked about neurocysticercosis as a main cause of epilepsy. Two researchers from Latin America wrote in and questioned how frequently this parasitic infection actually leads to epilepsy. Dr. Garcia responded.
Pediatric neurologists are not counseling young adults with epilepsy about reproductive issues as frequently as needed, according to a recent 10-year study. Some conversations, such as those about pregnancy and the potential effects of antiseizure medications, are almost nonexistent.
In 2008 at VUMC there were a group of doctors trying something unheard of on a handful of patients who signed up for their study. Half would receive deep brain stimulation (DBS) surgery in attempt to slow the progression of their early-stage Parkinson’s disease, and the others would not.
People with high blood pressure have a higher risk of cognitive impairment, including dementia, but a new study from researchers at Wake Forest University School of Medicine suggests that engaging in vigorous physical activity more than once a week can lower that risk.
Shlomo Melmed, MB, ChB, executive vice president of Medicine and Health Sciences and dean of the Medical Faculty at Cedars-Sinai, has received the Pituitary Society’s top honor for his four decades of pioneering achievements and leadership in the field of endocrinology.
A new study suggests that people who take a few common drugs may have a decreased risk of having a bleeding stroke due to a ruptured brain aneurysm. The study is published in the June 5, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Everybody has them. A Penn State Health expert with nearly 50 years of experience talks about the best way to treat headaches.
In their pursuit to discover the mechanism behind how RVCL does its damage, researchers found some clues to the DNA damage theory of aging
Deep brain stimulation procedures use electrical pulses to disrupt tiny portions of the brain and halt epileptic seizures or disease-related tremor. The therapy is invaluable, but the basic technology has not advanced in decades.
Thousands of American teens and their families are helping scientists learn more about the growth and development of the brain and its impacts on behavior, mental health and much more, through a national study called ABCD that also includes thousands of other young people nationwide.
Researchers at the Krieger Klein Alzheimer’s Research Center at Rutgers Brain Health Institute are launching a pioneering study to better understand the characteristics that place South Asian populations at heightened risk for Alzheimer’s disease.
The underdiagnosis of dementia, especially among Black and Hispanic patients, is a long-standing challenge in medicine.
Patients with Cushing’s syndrome who are recovering from surgery and wear a headband that tracks brain activity while they meditate may have less pain and better physical functioning compared with patients not using the device, suggests a study being presented Monday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.
Dana-Farber Cancer Institute researchers are leading 3 separate studies with encouraging results in treating patients with central nervous system (CNS) lymphoma, breast cancer, and glioblastoma. These findings are among more than 80 studies presented at ASCO that are led by Dana-Farber-affiliated researchers.
Announcement of contents of the June 2024 issue of Neurosurgical Focus
A roundup of the latest medical discoveries and faculty news at Cedars-Sinai.
Researchers at the Icahn School of Medicine at Mount Sinai and others have identified a neurodevelopmental disorder, caused by mutations in a single gene, that affects tens of thousands of people worldwide. The work, published in the May 31 online issue of Nature Medicine [DOI: 10.1038/s41591-024-03085-5], was done in collaboration with colleagues at the University of Bristol, UK; KU Leuven, Belgium; and the NIHR BioResource, currently based at the University of Cambridge, UK. The findings will improve clinical diagnostic services for patients with neurodevelopmental disorders.
Sleep medicine experts available for interview on breaking and trending news about obstructive sleep apnea, CPAP, and more
Susan Chipman, a pioneer in the field of cognitive science, has pledged a $1 million planned gift to the University of California San Diego's Department of Cognitive Science. The Susan E.F. Chipman and Robert G. Fitzgerald Graduate Fellowship Fund in Cognitive Science is the first of its kind in the UC San Diego department, which was the world's first department established in cognitive science.
For patients with chronic migraine, nerve decompression surgery effectively reduces the number of headache days – the outcome measure preferred by neurologists – along with other measures including the frequency and intensity of migraine attacks, reports a study in the June issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).
During pregnancy, the effects of therapeutical doses of amphetamine have been investigated on birth outcomes in humans. However, a thorough investigation of the mechanisms underlying the long-term effects of embryonal exposure to addictive doses of amphetamine remains largely unexplored.
A novel speech analysis tool that uses artificial intelligence successfully detected mild cognitive impairment and dementia in a Spanish-speaking population, according to research led by UT Southwestern Medical Center. The study, published in Frontiers in Neurology, provides preliminary support for the algorithm as an early screening tool that may help identify patients at risk of developing dementia.
Brain cancer is difficult to treat when it starts growing, and a prevalent type, known as a glioma, has a poor five-year survival rate.
While older drugs for epilepsy, taken while pregnant, have been shown in previous research to affect the creative thinking of children, a new study finds no effects on creativity for children born to those taking newer epilepsy drugs. This study is published in the May 29, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right